Geode Capital Management
CMND icon

Geode Capital Management’s Clearmind Medicine CMND Stock Holding History

Geode Capital Management’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-41
Closed -$27.9K – 4547
2024
Q2 		$27.9K Hold
41
– – ﹤0.01% 4398
2024
Q1 		$18.5K Buy
+41
New +$25.1K ﹤0.01% 4491
2023
Q4 		– Sell
-5
Closed -$10.2K – 4661
2023
Q3 		$10.2K Buy
5
+1
+25% +$4.58K ﹤0.01% 4725
2023
Q2 		$24.2K Hold
4
– – ﹤0.01% 4635
2023
Q1 		$58.7K Buy
+4
New +$167K ﹤0.01% 4482

Other funds holding CMND

GAM
Gotham Asset Management New York $43B AUM 34.97% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
CWG
Cornerstone Wealth Group Huntersville, North Carolina $1.69B AUM 28.24% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return

Geode Capital Management's CMND Position: Q3 2024 in Review

Geode Capital Management sold out of Clearmind Medicine (CMND) in Q3 2024, closing a stake of 41 shares — an estimated $27.9K sold.

Geode Capital Management first reported a position in CMND in Q1 2023 and held it in 5 quarters. The position peaked at $58.7K in Q1 2023. 8 funds tracked by Wall St. Rank hold CMND as of Q3 2024.

  • Geode Capital Management reported no remaining Clearmind Medicine position as of Q3 2024 after selling out during the quarter.
  • Geode Capital Management sold 41 Clearmind Medicine shares in Q3 2024, an estimated $27.9K.
  • Geode Capital Management first reported a position in Clearmind Medicine in Q1 2023 and held it in 5 quarters.
  • Geode Capital Management's Clearmind Medicine position peaked at $58.7K in Q1 2023.
  • 8 funds tracked by Wall St. Rank held Clearmind Medicine as of Q3 2024.

Based on Geode Capital Management's 13F filing for Q3 2024, filed 12 Nov 2024.